Stockscreener 앱 받기
49.51
3.02%
1.45
시간 외 거래:
49.91
0.40
+0.81%
Qiagen Nv 주식(QGEN)의 최신 뉴스
BlackRock’s Significant Stake in Qiagen Disclosed by AFM - TipRanks
Qiagen Announces Voting Rights Notification Involving BlackRock - TipRanks
QIAGEN launches long read sequencing panels for complex genomic analysis - StreetInsider
QIAGEN Expands NGS Portfolio with Launch of QIAseq xHYB Long Read Panels - Business Wire
What drives Qiagen N.V. stock priceRapid wealth multiplication - jammulinksnews.com
Qiagen N.V. Stock Analysis and ForecastJaw-dropping returns - jammulinksnews.com
Qiagen NV stock reaches 52-week high at 48.91 USD - Investing.com India
Is Qiagen N.V. a good long term investmentExceptional return forecasts - jammulinksnews.com
What analysts say about Qiagen N.V. stockMassive wealth growth - Autocar Professional
Qiagen Announces Significant Voting Rights Notification by BlackRock - TipRanks
Favorable Government Support Fuels Germany's Biotech Innovation and Commercialization: Market to Surpass USD 94 Billion by 2034 Led by QIAGEN, Thermo Fisher Scientific, Illumina and Roche - Yahoo Finance
Qiagen N.V. (NYSE:QGEN) is favoured by institutional owners who hold 79% of the company - simplywall.st
Fivespan Said to Build Stake in Life Sciences Group Qiagen - MSN
Qiagen and Gencurix partner for oncology tests - MSN
Qiagen NV stock hits 52-week high at 48.82 USD By Investing.com - Investing.com South Africa
QIAGEN Announces Managerial Share Transaction - TipRanks
Qiagen NV stock hits 52-week high at 48.82 USD - Investing.com Australia
QIAGEN N.V. to Release Results for Q2 2025 and Hold Webcast - Business Wire
QIAGEN NV : Deutsche Bank maintains a Buy rating - MarketScreener
QIAGEN Sets August 5 for Q2 2025 Earnings: Global Investors Briefing Across 3 Time Zones - Stock Titan
Baptista Research Begins Qiagen Coverage at Hold - MarketScreener
Qiagen Teams With Gencurix to Expand Digital PCR Cancer Assays - MSN
Qiagen N : announces adjustment of conversion price under its US$500,000,000 Convertible Bonds due 2031 - MarketScreener
Qiagen N : announces adjustment of conversion price under its US$500,000,000 Convertible Bonds due 2027 - MarketScreener
Qiagen N.V.(NYSE: QGEN) dropped from Russell 1000 Dynamic Index - MarketScreener
Ex-Dividend Reminder: Comcast, Qiagen and HA Sustainable Infrastructure Capital - Nasdaq
Qiagen Announces Managerial Share Transaction - TipRanks
Qiagen N.V. (QGEN) Expands MRD Testing with Tracer and Foresight Partnerships - MSN
QIAGEN Announces Election of Stephen Rusckowski as Chairman of S - GuruFocus
Qiagen (QGEN) Target Price Raised by B of A Securities | QGEN Stock News - GuruFocus
Qiagen stock reaches 52-week high at 48.24 USD - Investing.com
Barclays Starts Qiagen NV (QGEN) at Overweight - StreetInsider
Here's Why Qiagen (QGEN) is a Strong Value Stock - Nasdaq
Qiagen Announces BlackRock’s Significant Voting Rights Disclosure - TipRanks
Qiagen (QGEN) Just Flashed Golden Cross Signal: Do You Buy? - Yahoo.co
Incyte (INCY) Teams Up with QIAGEN to Boost Blood Cancer Diagnostic Solutions - MSN
QIAGEN and GENCURIX Announce QIAcuity Digital PCR IVD Assay Development Partnership - BioSpace
Incyte Stock Rises on QIAGEN Deal to Advance Blood Cancer Diagnostics - MSN
Qiagen’s Voting Rights Notification Highlights BlackRock’s Influence - TipRanks
BlackRock’s Significant Stake in Qiagen Revealed - TipRanks
2.06%
0.50%
자본화:
|
볼륨(24시간):